1-15 of 15
Lori Maness
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Hematopoietic Cell Transplantation (HCT) Frailty Is Associated with Lower Cognitive Function and Health-Related Quality of Life (HRQOL) in Older Adults Undergoing HCT

Thuy T Koll, Megan Kerns, Tanya M. Wildes, Vijaya Raj Bhatt, Krishna Gundabolu, Lori Maness, Michael Haddadin, Marcia Free, Elizabeth R Lyden, Daniel L Murman, Alfred L Fisher
Journal: Blood
Blood (2024) 144 (Supplement 1): 3550.
https://doi.org/10.1182/blood-2024-210392
Published: 2024
Journal Articles

Association between Malnutrition and Inpatient Mortality in Hematopoietic Stem Cell Transplant (HSCT) Population: A Nationwide Inpatient Sample (NIS) Database Analysis

Michael Haddadin, Adham Obedat, Farah Al-Bitar, Lori Maness, Krishna Gundabolu, Shyam Ajay Patel, Vijaya Raj Bhatt
Journal: Blood
Blood (2024) 144 (Supplement 1): 2125.
https://doi.org/10.1182/blood-2024-204507
Published: 2024
Journal Articles

Long-Term Results from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib

Jorge Cortes, Michael Deininger, Elza Lomaia, Beatriz Moiraghi, Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Lori Maness, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane F Apperley
Journal: Blood
Blood (2023) 142 (Supplement 1): 3164.
https://doi.org/10.1182/blood-2023-178790
Published: 2023
Journal Articles

Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial

Vijaya Raj Bhatt, Christopher Wichman, Thuy T Koll, Alfred Fisher, Tanya M. Wildes, Michael Haddadin, Ann Berger, James Olen Armitage, Sarah A. Holstein, Lori Maness, Krishna Gundabolu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4265.
https://doi.org/10.1182/blood-2023-178112
Published: 2023
Journal Articles

Molecular Response of ≤10% BCR::ABL1 IS Is Predictive of Positive Outcomes in Treatment-Resistant Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Treated with Ponatinib from the Phase 2 Optic Trial

Jane F. Apperley, Jorge E. Cortes, Elias Jabbour, Andreas Hochhaus, Timothy Hughes, Charles Chuah, Hugues de Lavallade, Michael W. Deininger, Jeffrey H. Lipton, Elza Lomaia, Lori Maness, Michael Mauro, James McCloskey, Beatriz Moiraghi, Carolina Pavlovsky, Christine Rojas, Philippe Rousselot, Tomasz Sacha, Moshe Talpaz, Anna Turkina, Maria Undurraga Sutton, Xiaowei Ren, Alexander Vorog, Gianantonio Rosti
Journal: Blood
Blood (2022) 140 (Supplement 1): 6760–6762.
https://doi.org/10.1182/blood-2022-157956
Published: 2022
Journal Articles

Older Adults with Acute Myeloid Leukemia (AML) Treated in a Pragmatic Trial: How Do Patients’ Function and Health-Related Quality of Life Change with Treatment?

Vijaya Raj Bhatt, Christopher Wichman, Zaid S. Al-Kadhimi, Thuy T. Koll, Alfred L Fisher, Ann Berger, James O. Armitage, Sarah A. Holstein, Lori Maness, Krishna Gundabolu
Journal: Blood
Blood (2022) 140 (Supplement 1): 8991–8992.
https://doi.org/10.1182/blood-2022-156310
Published: 2022
Journal Articles

Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial

Vijaya Raj Bhatt, Valerie K Shostrom, Ayman Saad, Betty K. Hamilton, Krishna Gundabolu, Lori Maness, Virender Kumar, Ram I Mahato, Lynette M. Smith, Taiga Nishihori, Stephanie J. Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 1379–1380.
https://doi.org/10.1182/blood-2022-156340
Published: 2022
Journal Articles

Three-Year Update from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib

Jorge E. Cortes, Michael W. Deininger, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Lori Maness, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane F. Apperley
Journal: Blood
Blood (2022) 140 (Supplement 1): 1495–1497.
https://doi.org/10.1182/blood-2022-157822
Published: 2022
Journal Articles

Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in Progress

Vijaya Raj Bhatt, Christopher Wichman, Alyssa C. Bouska, Lori Maness, Zaid S. Al-Kadhimi, Javeed Iqbal, James E. Talmadge, Krishna Gundabolu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12918–12919.
https://doi.org/10.1182/blood-2022-156316
Published: 2022
Journal Articles

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Clinical Trials & Observations
Jorge Cortes, Jane Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Kevin Arthur, Lori Maness, Moshe Talpaz, Michael Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael Deininger
Journal: Blood
Blood (2021) 138 (21): 2042–2050.
https://doi.org/10.1182/blood.2021012082
Published: 2021
Includes: Supplemental data
Journal Articles

A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

Edward Anthony Faber, Jr., DO, MS, Fausto R. Loberiza, Jr., MD, MS, Mojtaba Akhtari, Philip Bierman, MD, R. Gregory Bociek, MD, Lori Maness, M.D., Julie M Vose, MD
Journal: Blood
Blood (2011) 118 (21): 2040.
https://doi.org/10.1182/blood.V118.21.2040.2040
Published: 2011
Journal Articles

Trend Analysis of 5-Year All-Cause Mortality After Autologous Stem Cell Transplantation in Patients with Lymphoma and Multiple Myeloma

Mojtaba Akhtari, MD, James O. Armitage, Philip Bierman, MD, R. Gregory Bociek, MD, Edward Anthony Faber, Jr., DO, MS, Lori Maness, M.D., Julie M Vose, MD, Fausto R. Loberiza, Jr., MD, MS
Journal: Blood
Blood (2011) 118 (21): 842.
https://doi.org/10.1182/blood.V118.21.842.842
Published: 2011
Journal Articles

Marqibo ® (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) In Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)

Jeffrey A Silverman, PhD, Walter E. Aulitzky, MD, John Lister, MD, Lori Maness, M.D., Gary J Schiller, MD, Karen Seiter, MD, Scott Smith, MD, PhD, FACP, Wendy Stock, MD, Dina Ben Yehuda, Steven R. Deitcher, MD
Journal: Blood
Blood (2010) 116 (21): 2142.
https://doi.org/10.1182/blood.V116.21.2142.2142
Published: 2010
Journal Articles

Prolonged Administration of the Telomerase Vaccine GRNVAC1 Is Well Tolerated and Appears to Be Associated with Favorable Outcomes In High-Risk Acute Myeloid Leukemia (AML)

H. Jean Khoury, MD, FACP, Robert H. Collins, Jr, MD, William Blum, MD, Lori Maness, MD, Patrick Stiff, MD, Stephen M. Kelsey, MD, Anita Reddy, PhD, Jennifer A. Smith, PhD, John F. DiPersio, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2190.
https://doi.org/10.1182/blood.V116.21.2190.2190
Published: 2010
Journal Articles

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, In Older Patients with MDS Refractory to Hypomethylating Agents

Guillermo Garcia-Manero, MD, Selina Luger, MD, Parmeswaran Venugopal, MD, Lori Maness, MD, Meir Wetzler, MD, Jessica K Altman, MD, David F. Claxton, MD, Stephen Anthony Strickland, JR, MD, James M. Foran, MD, FRCPC, Stuart L Goldberg, MD, Judy Chiao, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 1857.
https://doi.org/10.1182/blood.V116.21.1857.1857
Published: 2010